Literature DB >> 7946184

Established risk factors and coronary artery disease: the Framingham Study.

P W Wilson1.   

Abstract

Long-standing risk factors for the development of coronary artery disease (CAD) have typically included age, blood levels of total and high-density lipoprotein (HDL) cholesterol, blood pressure, cigarette use, diabetes mellitus, and left ventricular hypertrophy on electrocardiography. Each of the traditional risk-factor measures has expanded in scope over time; for instance, systolic and diastolic blood pressure levels are each associated with the occurrence of CAD, and an individual need not be hypertensive to be at an increased risk. Although total (or low-density lipoprotein cholesterol) and HDL cholesterol are highly associated with CAD incidence, other newer lipid measures such as apolipoproteins A-I and B, and genetic markers have shown little or no additional effect in predicting CAD. Diabetes mellitus has been consistently associated with CAD but less data are available to demonstrate independent roles for obesity and regional adiposity. Although reports are more recent, hematologic factors such as fibrinogen concentration and leukocyte count have been consistently associated with CAD in observational studies. Prediction equations continue to emphasize the traditional biological factors and not behaviors. Among life-style habits such as diet, sedentary activity, and cigarette smoking, only the latter has been consistently used in CAD prediction because of its independent effect.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7946184     DOI: 10.1093/ajh/7.7.7s

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  89 in total

Review 1.  Measuring contextual characteristics for community health.

Authors:  Marianne M Hillemeier; John Lynch; Sam Harper; Michele Casper
Journal:  Health Serv Res       Date:  2003-12       Impact factor: 3.402

Review 2.  Gene silencing in DNA damage repair.

Authors:  H Soejima; K Joh; T Mukai
Journal:  Cell Mol Life Sci       Date:  2004-09       Impact factor: 9.261

3.  Cardiovascular risk reduction via increasing HDL cholesterol: the promise of the dal-OUTCOMES Trial.

Authors:  Kyaw Soe; Anis Alam; Charles Philip; Edison Ruiz; Keshwar Ramkissoon; Samy I McFarlane
Journal:  Curr Diab Rep       Date:  2011-02       Impact factor: 4.810

4.  Identification of risk factors for psoriatic arthritis: scientific opportunity meets clinical need.

Authors:  Alexis Ogdie; Joel M Gelfand
Journal:  Arch Dermatol       Date:  2010-07

5.  Scuba diving fatalities in Australia, 2001 to 2013: Diver demographics and characteristics.

Authors:  John Lippmann; Christopher Stevenson; David McD Taylor
Journal:  Diving Hyperb Med       Date:  2020-06-30       Impact factor: 0.887

Review 6.  Genetics of the Framingham Heart Study population.

Authors:  Diddahally R Govindaraju; L Adrienne Cupples; William B Kannel; Christopher J O'Donnell; Larry D Atwood; Ralph B D'Agostino; Caroline S Fox; Marty Larson; Daniel Levy; Joanne Murabito; Ramachandran S Vasan; Greta Lee Splansky; Philip A Wolf; Emelia J Benjamin
Journal:  Adv Genet       Date:  2008       Impact factor: 1.944

7.  Plasma bicarbonate and odds of incident hypertension.

Authors:  Ernest I Mandel; John P Forman; Gary C Curhan; Eric N Taylor
Journal:  Am J Hypertens       Date:  2013-08-13       Impact factor: 2.689

8.  Nebivolol (bystolic), a novel Beta blocker for hypertension.

Authors:  Olga Hilas; Danielle Ezzo
Journal:  P T       Date:  2009-04

9.  The relationships of sleep duration and mental health with electrocardiographic findings: a retrospective-cohort study in Okinawa, Japan.

Authors:  Kaoru Ichikawa; Tomoko Matsui; Tooru Tsunoda; Koji Teruya; Takamoto Uemura; Nobuo Takeda; Hiroteru Okamoto; Shinji Fukazawa
Journal:  Environ Health Prev Med       Date:  2008-06-05       Impact factor: 3.674

10.  Hypertension and combinations of cardiovascular risk factors. An epidemiologic case-control study in an adult population in Guadeloupe (FWI).

Authors:  L Foucan; J Bangou-Brédent; D K Ekouévi; J Deloumeaux; J E Roset; P Kangambega
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.